Clincosm LogoSign in Get a demo

esophagus cancer

Showing 1 - 25 of 86
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Long-term Survival and Quality of Life After Minimally Invasive

Not yet recruiting
  • Esophagus Cancer
  • +3 more
    • Ji'nan, Shandong, China
      Qilu Hospital of Shandong University
    Nov 19, 2023

    Esophagus Cancer Trial in Guangzhou (Cadonilimab, Paclitaxel and cisplatin, intensity-modulated radiotherapy)

    Not yet recruiting
    • Esophagus Cancer
    • Guangzhou, Guangdong, China
      Sun Yat-sen University
    Nov 20, 2023

    Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Wuhu (CEA-targeted CAR-T cells)

    Recruiting
    • Gastric Cancer
    • +7 more
    • CEA-targeted CAR-T cells
    • Wuhu, Anhui, China
      The First Affiliated Hospital of Wannan Medical College
    Nov 9, 2023

    Prevent Anastomotic Leakage After Esophagectomy Due to

    Not yet recruiting
    • Esophageal Cancer
    • +2 more
    • Eso-SPONGE®
    • Barcelona, Catalunya, Spain
      Hospital Clinic de Barcelona
    Oct 20, 2023

    Esophagus Cancer Trial in Chongqing (Catheterization, Single nerve block, Continuous nerve block)

    Recruiting
    • Esophagus Cancer
    • Catheterization
    • +3 more
    • Chongqing, China
      FulingCH
    Oct 16, 2023

    Cancer Diagnosis, LungCancer, Gastric Cancer Trial in China

    Not yet recruiting
    • Cancer Diagnosis
    • +7 more
      • Guangzhou, Guangdong, China
      • +6 more
      Sep 18, 2023

      Follow-up Strategy for Esophageal Cancer Patients

      Active, not recruiting
      • Esophagus Cancer
      • follow-up with different time intervals
      • Guangzhou, Guangdong, China
        Jianhua Fu
      Sep 13, 2023

      Colorectal Cancer, Esophagus Cancer, Gastric Cancer Trial in Hangzhou (CEA-targeted CAR-T cells)

      Recruiting
      • Colorectal Cancer
      • +6 more
      • CEA-targeted CAR-T cells
      • Hangzhou, Zhejiang, China
      • +1 more
      Sep 18, 2023

      Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)

      Recruiting
      • Gastric Cancer
      • +6 more
      • CEA CAR-T cells
      • Nanchang, Jiangxi, China
        The First Affiliated Hospital of Nanchang University
      Aug 23, 2023

      Dose to Cardiac Substructures on Survival in Esophageal Cancer

      Recruiting
      • Esophagus Cancer
        • Brest, France
          Chu Brest
        Aug 16, 2023

        Esophagus Cancer, Carcinoma Esophagus Trial (Supercharged TRAM esophagectomy, Conventional Esophagectomy)

        Not yet recruiting
        • Esophagus Cancer
        • Carcinoma Esophagus
        • Supercharged TRAM esophagectomy
        • Conventional Esophagectomy
        • (no location specified)
        Jul 13, 2023

        Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

        Not yet recruiting
        • Neoplasms
        • +5 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jun 16, 2023

        Relapse, Advanced Malignant Tumor, Non Small Cell Lung Cancer Trial in India (AUR106)

        Not yet recruiting
        • Relapse
        • +7 more
        • Visakhapatnam, Andhra Pradesh, India
        • +5 more
        May 7, 2023

        Colorectal Cancer, Liver Cancer, Gastric Cancer Trial in Créteil, Grenoble, Paris (Acupuncture intervention, No acupuncture)

        Not yet recruiting
        • Colorectal Cancer
        • +4 more
        • Acupuncture intervention
        • No acupuncture
        • Créteil, France
        • +4 more
        May 12, 2023

        Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal

        Not yet recruiting
        • Esophagus Cancer
        • +4 more
        • Intravenous injection of P-IL-2
        • P-IL-2 plus Anti-PD-1 Monoclonal Antibody
        • (no location specified)
        Apr 24, 2023

        Esophagus Cancer Trial in Xiamen (Tislelizumab, Paclitaxel-albumin, Carboplatin)

        Recruiting
        • Esophagus Cancer
        • Xiamen, Fujian, China
          ShanghaiZhongshan
        Apr 8, 2023

        Esophagus Cancer, Acupuncture Trial in Taichung (Acupuncture)

        Recruiting
        • Esophagus Cancer
        • Acupuncture
        • Acupuncture
        • Taichung, Taiwan
          China Medical University Hospital
        Mar 24, 2023

        Colorectal Cancer, Esophagus Cancer, Appendix Cancer Trial (FOX dose-escalation algorithm)

        Not yet recruiting
        • Colorectal Cancer
        • +4 more
        • FOX dose-escalation algorithm
        • (no location specified)
        Mar 24, 2023

        Evaluation of Early Signs of Myocardial Injury After Thoracic

        Recruiting
        • Lung Non-Small Cell Carcinoma
        • +2 more
        • Biospecimen Collection
        • +3 more
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Feb 6, 2023

        Esophagus Cancer, Esophageal Cancer, Esophageal Tumors Trial in Pittsburgh (ActivSight)

        Not yet recruiting
        • Esophagus Cancer
        • +9 more
        • ActivSight
        • Pittsburgh, Pennsylvania
          University of Pittsburgh Medical Center - Dept of Cardiothoracic
        Jan 31, 2023

        Retrospective Review of Esophageal Cancer at MSKCC

        Recruiting
        • Esophageal Cancer
        • Esophagus Cancer
        • Esophagectomy
        • New York, New York
          Memorial Sloan Kettering Cancer Center (All Protocol Activities)
        Jan 23, 2023

        Esophagus Cancer Trial in Tianjin (Camrelizumab, Paclitaxel, Cisplatin)

        Recruiting
        • Esophagus Cancer
        • Tianjin, Tianjin, China
          Affiliated Cancer Hospital of Tianjin Medical University
        Nov 24, 2022

        Sequence and Time-of-day Infusion of immunoCHemotherapy Affect

        Completed
        • Esophagus Cancer
          • Guangzhou, Guangdong, China
            Guangdong Provincial People's Hospital
          Nov 24, 2022

          Esophagus Cancer Trial in Beijing (Qizhu Yuling Prescription, Placebo)

          Recruiting
          • Esophagus Cancer
          • Qizhu Yuling Prescription
          • Placebo
          • Beijing, Beijing, China
          • +2 more
          Nov 19, 2022

          Advanced Solid Tumor, Sarcoma, HNSCC Trial in China (T3011)

          Recruiting
          • Advanced Solid Tumor
          • +6 more
          • T3011
          • Hefei, Anhui, China
          • +18 more
          Oct 30, 2022